Table 3.
Disease | Condition | Target | Methylation effect | Read-out | Cell/tissue | Reference |
---|---|---|---|---|---|---|
Folate and Vitamin B12 deficiency |
PSEN1
BACE |
↓ | SAM/SAH↓; PSEN-1 and BACE↑; Aβ↑ | SK-N-BE neuroblastoma cells | [6, 139] | |
B vitamin deprivation |
PSEN1
BACE |
↓ | SAM/SAH↓; PSEN-1 and BACE↑; Aβ↑ | TgCRND8 mice | [141] | |
B vitamin deficiency | GSK3β | ↓ | GSK3β↑;PP2A activity↓; phosphorylated tau↑ | SK-N-BE cells | [142] | |
SAH (SAM and PPMT) |
PP2Ac
PP2A |
↓ ↓ (↑) |
Tau phosphorylation↑; APP phosphorylation at Thr-668↑; β-Secretase-cleaved APP fragments↑ Aβ peptides↑ (tau dephosphorylation↑; α-secretase-cleaved APP fragment↑) |
TgCRND8 mice Neuro-2a cells |
[148] | |
High-methionine, low-folate diet | PP2A | ↓ | PPMT↓;LCMT-1↓; demethylated PP2ABα↓ | Cystathionine-β-synthase +/– mice | [173] | |
Folate deficiency, folate-deficient diets | PP2A | ↓ | Phosphorylated tau↑ | Neuro-2a cells C57BL/6J mice |
[174] | |
Methotrexate | Phosphorylated tau↑ | Rat primary neuron cells | [175] |
SAH = S-adenosylhomocysteine; PSEN-1 = presenilin 1; BACE = β-site amyloid precursor protein-cleaving enzyme; Aβ = amyloid β; SK-N-BE = ??; PP2A = protein phosphatase 2A; APP = amyloid precursor protein; PPMT = PP2A methyltransferases; LCMT-1 = leucine carboxyl methyltransferases 1